Top Genomics And Proteomics Stories


Comment & Analysis »

GlobalData Healthcare

Tempered optimism for early IDO + PD1 dual checkpoint blockade data in advanced urothelial carcinoma

Preliminary results were presented at the ASCO 2017 meeting for the Phase I/II ECHO-202/KEYNOTE-037 trial, investigating Incyte’s IDO inhibitor, epacadostat, in combination with Merck & Co’s...

Tempered optimism for early IDO + PD1 dual checkpoint blockade data in advanced urothelial carcinoma
GBI Research

Fighting blindness with bugs: can gene infection save people’s sight?

Fighting blindness with bugs: can gene infection save people’s sight?
GlobalData Healthcare

The Human Microbiome: On the cutting edge of future cures for many diseases?

The Human Microbiome: On the cutting edge of future cures for many diseases?
GBI Research

CRISPR: are genetic mutants the future of disease treatment?

CRISPR: are genetic mutants the future of disease treatment?
 

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

Company Releases »

Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Kemwell
Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Paediatric Clinical Trials 2016

SMI
Paediatric Clinical Trials 2016

Kemwell: Keeping You Competitive

Kemwell Kemwell: Keeping You Competitive

Emerging Biotech Investment: Strategic Analysis of Private Equity and Venture Capital Funding

GlobalData
Emerging Biotech Investment: Strategic Analysis of Private Equity and Venture Capital Funding

High-Quality Human Tissues and Biological Materials

Tissue Solutions High-Quality Human Tissues and Biological Materials

Genomics And Proteomics Insights »

Companies »